🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this placebo controlled study is to evaluate the safety and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-25
Trial ID
NCT01949090
Treatments Being Tested
This is a prospective observational study with recruitment of healthy volun...
Status
Completed
Location
University Clinic of Respiratory and Allergic Diseases
Start Date
2009-11
Trial ID
NCT01178918
This is a randomized, double-blinded, Phase II study in healthy males and n...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2018-02-14
Trial ID
NCT03312231
Treatments Being Tested
The purpose of this phase IIb study is to demonstrate the consistency of th...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-27
Trial ID
NCT00321763
Treatments Being Tested
The purpose of this study is to see how the body reacts to different streng...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00964951
Treatments Being Tested
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-08
Trial ID
NCT03275389
Groups 1 to 3 will receive two vaccinations on Day 0 and Day 21. Group 1 wi...
Status
Completed
Location
Privatklinik Leech
Start Date
2011-05
Trial ID
NCT01353534
Treatments Being Tested
In order to find the formulation leading to a maximal increase of the immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-05
Trial ID
NCT00540228
Treatments Being Tested
This is a randomized, multi-site, adaptive, open-label clinical trial compa...
Status
Terminated
Location
UCLA Medical Center: Division of Rheumatology
Start Date
2021-08-13
Trial ID
NCT05000216
Treatments Being Tested
This BARDA-sponsored, randomized, double-blind, phase 2 study is designed t...
Status
Completed
Location
DelRicht Research - Atlanta
Start Date
2024-08-21
Trial ID
NCT06560151
Treatments Being Tested